Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Current Key Topics in Fosfomycin"'
Autor:
L, Morata, A, Soriano
Publikováno v:
Revista Española de Quimioterapia
Osteoarticular infections include septic arthritis and osteomyelitis, with Gram-positive microorganisms isolated most frequently. In recent years, there has been an increase in the number of resistant strains in this type of infection, which complica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cf864a491f22fdceeecf0dcfe7855703
https://pubmed.ncbi.nlm.nih.gov/31131590
https://pubmed.ncbi.nlm.nih.gov/31131590
Autor:
M, Díez-Aguilar, R, Cantón
Publikováno v:
Revista Española de Quimioterapia
The discovery of fosfomycin more than 40 years ago was an important milestone in antibiotic therapy. The antibiotic’s usefulness, alone or in combination, for treating infections caused by multidrug-resistant microorganisms is clearer than ever. Bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1073111f90b2fca6704fdc78d86b0219
https://pubmed.ncbi.nlm.nih.gov/31131587
https://pubmed.ncbi.nlm.nih.gov/31131587
Autor:
I, López-Montesinos, J P, Horcajada
Publikováno v:
Revista Española de Quimioterapia
Urinary tract infections are one of the most common health problems and entail a high consumption of health system resources. Due to the increase in global antibiotic resistances in recent years, it is increasingly common to find uropathogens with mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cada72fe2b9b660ef287c2d57ee6d85c
https://pubmed.ncbi.nlm.nih.gov/31131591
https://pubmed.ncbi.nlm.nih.gov/31131591
Publikováno v:
Revista Española de Quimioterapia
Scopus-Elsevier
Europe PubMed Central
Scopus-Elsevier
Europe PubMed Central
To date, there has been little experience in using fosfomycin in children. However, its broad spectrum of action and excellent safety profile have renewed interest in this antibiotic, especially for treating infections by multidrug-resistant bacteria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b43c2a43bfa631ef709645c03e5299f7
https://pubmed.ncbi.nlm.nih.gov/31131593
https://pubmed.ncbi.nlm.nih.gov/31131593
Publikováno v:
Revista Española de Quimioterapia
Europe PubMed Central
Europe PubMed Central
Fosfomycin is a bactericidal antibiotic that interferes with cell wall synthesis. The drug therefore has a broad spectrum of activity against a wide range of Gram-positive and Gram-negative bacteria. Both the European Medicines Agency (EMA) and the U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d68f07638e0a82a7390a58c22db92174
https://pubmed.ncbi.nlm.nih.gov/31131586
https://pubmed.ncbi.nlm.nih.gov/31131586
Autor:
A, Rodríguez-Gascón, A, Canut-Blasco
Publikováno v:
Revista Española de Quimioterapia
Fosfomycin, a low molecular weight and hydrophilic drug with negligible protein binding, is eliminated almost exclusively by glomerular filtration, whose clearance is subject to patient renal function. The volume of distribution approximates to the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::007d905a7b6d0af7be0b122adc607303
https://pubmed.ncbi.nlm.nih.gov/31131588
https://pubmed.ncbi.nlm.nih.gov/31131588
Autor:
J, Ruiz Ramos, M, Salavert Lletí
Publikováno v:
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Revista Española de Quimioterapia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Revista Española de Quimioterapia
The alarming increase in antibiotic resistance rates reported for various pathogens has resulted in the use of alternative treatment policies. Given the fairly limited availability of new antimicrobial drugs, the reassessment of older antibiotics is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0876fc667a0e05c4770f20bb306b4d96
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11125
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11125
Publikováno v:
Europe PubMed Central
Revista Española de Quimioterapia
Scopus-Elsevier
Revista Española de Quimioterapia
Scopus-Elsevier
Due to the increase in antimicrobial resistance, strategies such as antimicrobial stewardship programs (ASP) have been developed to improve the clinical results, decrease the adverse effects and the development of resistances and ensure cost-effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6741848b384281aa38b4d380678d4a4f
http://europepmc.org/abstract/med/31131594
http://europepmc.org/abstract/med/31131594